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By Holger Ho¨fling1 and Robert Tibshirani2
Stanford University
Given a predictor of outcome derived from a high-dimensional
dataset, pre-validation is a useful technique for comparing it to com-
peting predictors on the same dataset. For microarray data, it allows
one to compare a newly derived predictor for disease outcome to stan-
dard clinical predictors on the same dataset. We study pre-validation
analytically to determine if the inferences drawn from it are valid. We
show that while pre-validation generally works well, the straightfor-
ward “one degree of freedom” analytical test from pre-validation can
be biased and we propose a permutation test to remedy this prob-
lem. In simulation studies, we show that the permutation test has the
nominal level and achieves roughly the same power as the analytical
test.
1. Introduction. Suppose that we have a prediction rule derived on a
high-dimensional dataset. It is often of interest to compare the new predic-
tion rule to competing rules in order to determine if the new rule provides
any additional benefit. For example, the new prediction rule might be based
on microarray expression values, while the competing predictors are clini-
cal, nongenomic measurements. Doing the comparison between the new and
competing rules on the same dataset (the “re-use” method) would favor the
new rule as it was derived on this same dataset. Another approach would be
to split the data into separate training and test datasets, build the predictor
on the training set and then fit it along with competing predictors on the
test set [see Chang et al. (2005) for an example]. However, with limited data,
this may severely reduce the accuracy of the new prediction rule and/or the
test set may be too small to have adequate power for the comparison.
Pre-validation (PV) [see Tibshirani and Efron (2002)] offers another ap-
proach to the problem of comparing a newly derived prediction rule to other
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Fig. 1. A schematic of the pre-validation process. The cases are divided up into (say)
10 equal-sized groups. Leaving out one of the groups, a prediction rule is derived from
the data of the remaining 9 groups. This prediction rule is then applied to the left out
group, giving the pre-validated predictor y˜ for the cases in the left out group. Repeating
this process for every group yields the pre-validated predictor y˜ for all cases. Finally, y˜
is included in a logistic regression model together with the clinical predictors to assess its
relative strength in predicting the outcome.
predictors on the same dataset the new rule was derived on. Pre-validation
is similar to cross-validation, but instead of directly estimating the predic-
tion error, it constructs a “fairer” version of the predictions on the data. It
uses a process similar to cross-validation to construct predictions for each
sample, using training features for the other observations. Thus, the result of
pre-validation is not an estimate of error (as in cross-validation), but rather
a set of pre-validated predictions, one for each sample. These predictions do
not have the inherent bias associated with the re-use method. Before going
into more details, we explain how pre-validation works on an example (see
also Figure 1).
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We have microarray data for n patients with breast cancer. On each array,
measurements on p genes were taken. Also available are several nonmicroar-
ray based predictors, which are commonly used in clinical practice (e.g., age,
tumor size . . . ) to predict if the patient’s prognosis is poor or good. We want
to use the microarray data in order to predict the prognosis of a patient. In
PV, the n patients are divided into K-folds. Leaving out one fold, a predic-
tion rule using the microarray data for the remaining K − 1 folds is fit (the
internal model). Using this rule, the cancer types for the patients in the left
out fold are predicted. This way, the data of the left out fold is not used in
building the rule and therefore no overfitting occurs. Repeating this proce-
dure for every fold yields a vector of predictions, which we call pre-validated.
The predicted response for a given patient derives from that patient’s covari-
ates through a prediction rule based on independent data. The pre-validated
predictor can now be compared to the other nonmicroarray-based predic-
tions using a logistic regression model (the external model). If the coefficient
of the pre-validated predictor in the logistic regression model is significant,
we conclude that the new microarray-based prediction rule has an indepen-
dent contribution over the existing rules. The effect of PV is to remove much
of the bias that arises from using the same data to build the new prediction
rule and compare it to the already established ones.
Pre-validation constructs a fairer version of our predictor that can be used
on the same dataset and will act like a predictor applied to a new external
dataset. That is, a single pre-validated predictor should behave as if its pre-
diction rule was derived on an independent dataset and therefore act just
like a regular predictor in a regression model. In particular, standard tests
for significance of the pre-validated predictor should work. In this article we
will show that pre-validation is only partially successful: while the coefficient
estimate for the pre-validated predictor is generally good, the standard ana-
lytical tests (e.g., t-test) can be biased, with a level differing from the target
level. In this paper we propose a permutation test to solve this problem.
The focus of this paper is the statistical test of significance of the new
prediction rule. However, as pointed out in Pepe et al. (2004) and Ware
(2006), statistical significance does not necessarily imply scientific or clini-
cal significance. For example, a predictor that improves the misclassification
rate of a model from 55% to 60% might be statistical significant, but the
overall model might be too inaccurate to use in practice. On the other hand,
an improved misclassification rate may appear relevant, however, it may be
due to chance and statistically insignificant. Therefore, it is important to es-
tablish statistical significance as well as practical relevance. With respect to
statistical significance, we can use tests on the pre-validated predictor which
should be unbiased to give an accurate answer. In order to establish prac-
tical relevance measures like prediction error, true positive fraction (TPF)
and false positive fraction (FPF) should be examined. For pre-validation,
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Tibshirani and Efron (2002) suggest a method to estimate the improvement
in prediction error when using the newly developed prediction method. They
show that their method works well and removes much of the bias of the re-
use method. Their methodology can easily be extended to other measures
such as TPF and FPF. In this article we establish that standard analyti-
cal tests in regression models for a pre-validated predictor are biased. This
bias may lead researchers to conclude that a new prediction rule is an im-
provement over other predictors even if the new rule would not have been
significant with an unbiased test. We propose a permutation test to remedy
this problem.
In Section 3 PV is applied to two different prediction methods on a mi-
croarray dataset of breast cancer patients in order to illustrate how it is
used in practice. In Section 4 we will establish the bias of the standard test
analytically in the simple setting with a linear internal and a linear external
model. Section 5 outlines the models that are used in the simulations, the
amount of bias of the analytical test in these models and the permutation
test. Section 6 presents the results of the simulations.
2. Pre-validation. As mentioned above, deriving a prediction rule and
comparing it to other rules on the same dataset can lead to a bias in favor
of the new rule due to overfitting. This bias can be very large and an example
of this effect will be shown later in Section 3.
One way to avoid overfitting is to use separate training and test datasets as
in Chang et al. (2005). However, as this is not a very efficient use of the data,
we can extend this approach in a straightforward fashion by cross-validation,
which is just K applications of the training/test dataset approach. This
procedure would then work as follows:
1. Divide the data in K separate groups.
2. Leave out one group and derive the prediction rule over the remaining
K − 1 groups.
3. Using the new prediction rule, predict the outcome for the left out group.
4. Compare the strength of the prediction to the already existing predictors
for the outcome (e.g., in a linear or logistic regression model, depending on
the type of outcome) only in the left out group. Test if the new predictor
is significant.
5. Repeat steps 2–4 for every group and average the results.
However, depending on the choice of K, there are tradeoffs. If K is small, say
2 or 3, the prediction rule is derived on a smaller set of data, thus possibly
losing accuracy. In situations as with microarray data, where the number of
observations is usually small compared to the amount of available data, the
reduction of prediction strength due to the lower number of observations can
be substantial. On the other hand, if K is, say, 4 or larger, the comparison
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to the already existing prediction rules has to be done on a very small
number of observations. If there are 5 (say) other predictors and a total of
50 observations, then with K = 5, the comparison of the new rule to the
5 old ones would have to be done using only 10 observations—it is very
unlikely to find significant effects under these circumstances.
Pre-validation (see Figure 1) changes this procedure to avoid the for-
mentioned problems:
1. Divide the data in K separate groups.
2. Leave out one group and derive the prediction rule over the remaining
K − 1 groups.
3. Using the new prediction rule, predict the outcome for the left out group.
4. Repeat steps 2 and 3 for each group. Collect the predictions into a vector
such that one prediction exists for every observation in every group (we
call this predictor “pre-validated”).
5. Compare the strength of the prediction to the already existing predictors
for the outcome (e.g., in a linear or logistic regression model, depending
on the type of outcome) using all observations and the predictor derived
above. Test if the new predictor is significant.
The main difference of PV to the CV method above is that instead of eval-
uating the performance on every test set separately and then averaging the
results, PV collects a vector with pre-validated predictions for every sample.
The comparison to competing predictors is done afterward.
Within PV, any prediction rule can be used, even if the rule itself esti-
mates its parameters by cross-validation. An example of this can be seen in
Section 3.2. With respect to the number of folds used in PV, K is usually
chosen to be 5 or 10. Leave-one-out PV (K = n) leads to high variance in
estimates and lower values would decrease the size of the training set too
much, as already discussed above. However, as in PV, the predictions for all
observations are collected before the comparison to the existing predictors,
a high value of K does not compromise the power of this comparison.
When comparing the pre-validated predictor to the existing predictors,
usually a linear or logistic regression model is fitted (depending on the out-
come). The new prediction rule is judged to make a significant improvement
over the old rules if the coefficient of the pre-validated predictor is signif-
icantly different from 0. As the new rule predicts the outcome, significant
values for the coefficient would be positive. Therefore, instead of a 2-sided
test of βPV = 0 vs. βPV 6= 0, we can get more power by doing a one-sided
test βPV = 0 vs. βPV > 0. For this, usually the standard analytical tests
for the model (i.e., t-statistic or z-score) are used. However, as will be seen
in Sections 4 and 6, this analytical test is biased in many situations. We
propose to use a permutation test instead, which is explained in detail in
Section 5.3 and the performance of which is studied in Section 6. In the next
section we want to illustrate how PV works in practice with two examples.
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3. Analysis of breast cancer data. Here we apply PV to the dataset
in van’t Veer et al. (2002) using the permutation test and compare it to
the analytical results. The data consists of microarray measurements on
4918 genes over 78 patients with breast cancer. Forty-four of these belong
to the good prognosis group (survival of more than 5 years), 34 have a
poor prognosis. Apart from the microarray data, a number of other clinical
predictors exist:
• Tumor grade (good: 1, 2; poor: 3)
• Estrogen receptor (ER) status (good: ≤10; poor: >10)
• Progestron receptor (PR) status (good: ≤10; poor: >10)
• Tumor size (mm) (good: ≤20; poor: >20)
• Patient age (yrs) (good: ≤40; poor: >40)
• Angioinvasion (good: 0; poor: 1)
In order to predict the prognosis of a patient, we try two models. The first
has been proposed by van’t Veer et al. (2002), the second is a L1 penalized
logistic regression model.
3.1. Van’t Veer et al. (2002) model. Based on the microarray data,
van’t Veer et al. (2002) constructed a predictor for the cancer prognosis in
the following way:
1. Select the 70 genes that have the highest correlation with the 78 class
labels.
2. Find the centroid vector of the good prognosis group.
3. Compute the correlation of each case with the centroid of the good prog-
nosis group. Find the cutoff such that only 3 cases in the poor prognosis
group are misclassified.
4. Classify any new case as good prognosis if their correlation with the
centroid is larger than the cutoff.
The predictor from this model is, like the clinical predictors, an indicator
variable. Using a continuous response (e.g., probability of being in the poor
prognosis group) would be possible, however, we use indicator variables as
it is a better match to the clinical predictors, which are also indicators.
Using other models is also an option which we explore with the next ex-
ample. However, as we only want to illustrate how PV works at this point,
we do not investigate if there are any other models that possibly give better
performance on this dataset. In fact, as we can see in Table 1, the model pro-
posed by van’t Veer et al. (2002) performs better than the penalized logistic
regression shown below.
An important part of the prediction method is the selection of the top 70
genes. In K-fold PV, this selection of the top genes is being repeated sepa-
rately on each of the K training sets consisting of (K − 1) folds as the first
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step of finding the prediction rule. This way, the top genes used in the predic-
tion are not necessarily the same across the K folds.
Zhu, Ambroise and McLachlan (2006) have shown that this reevaluation is
important as selecting the top genes in a pre-processing step and keeping
them fixed across the folds can lead to biased results.
One option to judge the performance of the new prediction rule is to eval-
uate its univariate prediction error using CV (see Table 1). However, as we
cannot assess this way if two predictors complement each other and therefore
improve performance if used together or not, we instead do a multivariate
comparison using a logistic regression with the pre-validated predictor as
well as the other clinical predictors.
The result of the model fitting with and without using PV can be found
in Table 2. We can immediately see how the significance of the microarray
predictor is reduced when 10-fold PV is being used and thus the effect of
fitting and testing the model on the same data removed. However, as PV
chooses random folds, the results depend on the choice of folds. In order
to get a clearer picture of the significance of the microarray predictor, we
repeated the 10-fold PV 100 times and averaged the resulting p-values for
the analytical and the permutation tests (see Table 3). The analytical test
declares the microarray predictor to be significant, however, all 3 permuta-
tion test statistics do not give significant results, though the difference of
the analytical test to the z-score permutation test is quite small. A possi-
ble explanation for these different results is the bias of the analytical test,
which we investigate in Sections 4 and 5.2. We also show in Section 6 that
the permutation test does not suffer from this problem.
3.2. L1 penalized logistic regression. As a second example to illustrate
pre-validation, we use a logistic regression model to predict the prognosis of
Table 1
Error rates of the new prediction rules and the
clinical predictors. The rates for the new
prediction rules are based on 100 runs of 10-fold
CV
Predictor Error rate
van’t Veer et al. (2002) 0.321
PLR 0.379
Grade 0.333
ER 0.616
Angio 0.333
PR 0.589
Age 0.654
Size 0.320
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a patient based on the microarray data. Penalized logistic regression (PLR)
has been shown to work well for predicting outcomes using gene expression
on other datasets [see Zhu and Hastie (2004)] and here we use an L1 penalty
as it implicitly performs variable selection on the genes [see Park and Hastie
(2007) for an algorithm]. The penalty parameter is chosen such that exactly
5,10, . . . ,45 or 50 genes are included in the model and the optimal number
of genes is determined by cross-validation. The exact procedure for pre-
validating this cross-validated model is then:
1. Divide the data into K folds.
2. Set aside one fold as the test set, the remaining K − 1 folds are the
training set.
Table 2
Summary of the coefficients in the external logistic model with 10-fold PV and without
PV using the van’t Veer method for prognosis prediction. For each coefficient a test for
β = 0 based on the z-score and the deviance is given. All p-values are for two-sided tests
except for the z-score p-value of the van’t Veer predictor, which is a one-sided p-value for
testing β = 0 versus β > 0
Predictor Method Coefficient SD z-score p-value ∆ Deviance p-value (dev)
van’t Veer No PV 4.10 1.09 3.75 0.9× 10−4 25.01 5.6× 10−7
10-fold PV 1.54 0.71 2.17 0.015 5.00 0.025
Grade No PV −0.70 1.00 −0.70 0.497 0.51 0.475
10-fold PV 0.56 0.75 0.75 0.452 0.56 0.453
ER No PV −0.55 1.04 −0.53 0.596 0.28 0.596
10-fold PV −0.64 0.90 −0.71 0.475 0.52 0.472
Angio No PV 1.21 0.82 1.48 0.139 2.29 0.130
10-fold PV 1.35 0.65 2.08 0.038 4.57 0.033
PR No PV 1.21 1.06 1.15 0.251 1.39 0.238
10-fold PV 0.43 0.83 0.51 0.609 0.27 0.606
Age No PV −1.59 0.91 −1.75 0.081 3.48 0.062
10-fold PV −1.46 0.69 −2.10 0.035 4.82 0.028
Size No PV 1.48 0.73 2.03 0.043 4.37 0.037
10-fold PV 0.84 0.60 1.40 0.161 1.96 0.162
Table 3
p-values for the van’t Veer predictor over 100 runs of the pre-validation procedure. The
mean values are reported as well as the percentage below the levels 0.01, 0.05 and 0.1
Statistic Mean % <0.01 % <0.05 % <0.1
Analytical z-score 0.046 15 66 91
Permutation with β 0.095 1 27 57
Permutation with z-score 0.050 17 62 86
Permutation with deviance 0.139 0 21 42
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Table 4
Summary of the coefficients in the external logistic model with 10-fold PV and without
PV based on the PLR model for prognosis prediction. For each coefficient a test for β = 0
based on the z-score and the deviance is given. All p-values are for two-sided tests except
for the z-score p-value of the PLR predictor, which is a one-sided p-value for testing
β = 0 versus β > 0
Predictor Method Coefficient SD z-score p-value ∆ Deviance p-value (dev)
PLR No PV 5.62 1.45 3.88 0.5× 10−4 39.33 3× 10−10
10-fold PV 0.72 0.65 1.10 0.135 1.23 0.268
Grade No PV 0.69 0.99 0.70 0.487 0.48 0.488
10-fold PV 0.73 0.77 0.95 0.343 0.90 0.342
ER No PV 0.33 1.65 0.20 0.841 0.04 0.840
10-fold PV −0.58 0.87 −0.67 0.504 0.45 0.501
Angio No PV 1.05 0.91 1.15 0.250 1.34 0.247
10-fold PV 1.38 0.64 2.16 0.031 4.94 0.026
PR No PV 1.41 1.60 0.88 0.380 0.85 0.356
10-fold PV 0.21 0.81 0.26 0.795 0.07 0.794
Age No PV 1.05 1.31 0.80 0.425 0.70 0.402
10-fold PV −1.28 0.65 −1.97 0.049 4.06 0.044
Size No PV 0.75 0.89 0.85 0.395 0.71 0.401
10-fold PV 1.13 0.58 1.93 0.053 3.83 0.050
3. Fit the penalized logistic regression model on the training set. Use CV
on the training set to find the optimal number of genes.
4. Using the model with the cross-validated number of genes, predict the
outcome on the test set.
5. Repeat steps 2–4 for all K folds.
6. Compare the pre-validated predictor to the clinical predictors in a logistic
regression model.
As can be seen by this example, PV also works with prediction methods
that rely on CV to estimate their parameters. The results using PLR can be
seen in Tables 4 and 5. As in the example above, if no PV is being used, the
predictor appears to be highly significant. However, using PV, the analytical
test gives a one-sided p-value of 0.1349, which is not significant. Using the
permutation tests instead confirms this result.
Overall we can see that the method proposed by van’t Veer et al. (2002)
performs better on this dataset. In the next section we analytically show
in a simple case that the analytical test of significance of a pre-validated
predictor based on the t-statistic is biased.
4. Analytical results on the bias of tests for pre-validated predictors.
An analytical treatment of the distribution of test statistics in the external
model is very difficult in the general case. However, the problem becomes
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tractable in a simplified setting. Consider PV with K = n, that is, leave-one-
out PV. Assume that p < n and use a linear regression model for building
the new prediction rule. Let there be e other external predictors for the
same outcome y. Let X be the n× p matrix with the data used for the new
prediction rule.
We assume that X and y have the following distributions:
Xij ∼N(0,1) i.i.d. ∀i= 1, . . . , n; j = 1, . . . , p
and
yi ∼N(0,1) i.i.d. ∀i= 1, . . . , n
independent also of X . So here our data X is independent of the response y
and we can therefore explore the distribution under the null in the external
model (βPV = 0).
4.1. No other predictors. For simplicity, let us first consider the case with
e = 0, that is, no other predictors. As a first step, we need an expression
for the prediction using the internal linear model and leave-one-out pre-
validation. Here let H =X(XTX)−1XT be the projection matrix used in
linear regression. Let D be the matrix with the diagonal elements of H .
Then the leave-one-out pre-validated predictor is
y˜ = (I −D)−1(H −D)y =: Py,
where I is the identity matrix.
Now use y˜ as the sole predictor in the external model, which is also linear.
As there are no other predictors, this may not seem to make much sense, as
the hypothesis that there is no relationship between X and y could be tested
right away in the internal model. We apply the external model anyway, as it
is very instructive as to what the problem is in more complicated settings.
So we now consider the model
y = βPV y˜+ ε,
where ε∼N(0, σ2 · I). Then under these conditions, the following theorem
holds:
Table 5
p-values for the PLR predictor over 100 runs of the pre-validation procedure. The mean
values are reported as well as the percentage below the levels 0.01, 0.05 and 0.1
Statistic Mean % <0.01 % <0.05 % <0.1
Analytical z-score 0.404 0 4 13
Permutation with β 0.249 0 3 10
Permutation with z-score 0.275 0 6 14
Permutation with deviance 0.299 1 10 17
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Theorem 1. Under the assumptions described above, the t-statistic for
testing the hypothesis βPV = 0 has the asymptotic distribution
t=
ˆβPV
sˆd( ˆβPV )
d→ C − p√
C
as n→∞,
where C ∼ χ2p.
Proof. See Appendix A.1. 
As it can be seen here, the statistic is not t-distributed as in a regular
linear regression. This can lead to biases when the t-distribution is used for
testing. The size of the bias will be explored numerically later in Section 5.2.
4.2. Other predictors related to the response y. Now assume that we
have several outside predictors for the response. As these are usually based
on different data than X , we define the distribution of the outside predictors
based on y and not on the internal model. So let Z be a n× e matrix with
Zik = yi + γik,
where γik ∼ N(0, σ2k) i.i.d. ∀ i = 1, . . . , n; k = 1, . . . , e. Thus, the additional
predictions are perturbed versions of the true response.
The internal model for the prediction of y using X is the same as before.
The external linear model now becomes, however,
y = y˜βPV +Zβ + ε.
Again we want to test if βPV = 0. In a linear model, this is usually done by
calculating the t-statistic and calculating the quantile using the t-distribution
with the right degrees of freedom. The following theorem gives the asymp-
totic distribution of the t-statistic under these assumptions.
Theorem 2. Under the setup described above, the t-statistic for testing
βPV = 0 in the external linear model has the asymptotic distribution
t=
βˆPV
sˆd(βˆPV )
d→ (N
TN − p)√
NTN
− N
TA(11T +Cov(γ))−11√
NTN(1− 1T (11T +Cov(γ))−11)
as n→∞,
where N ∼ N(0, Ip), A = (A1, . . . ,Ae) with Ak ∼ N(0, σ2k · Ip)), 1 = (1, . . . ,
1)T ∈Re and Cov(γ) = diag(σ21 , . . . , σ2e).
Proof. See Appendix A.2. 
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We can see that the asymptotic distribution of the t-statistic is not a
t or normal distribution, as we already observed in the simple case above
without external predictors.
In the next section, by using simulations, we will investigate the extent
of the bias when the testing is done using a t-distribution.
5. Models, bias and permutation test.
5.1. Models used in the simulations. In the section above we have seen
that in the simple case where the internal and external models are linear
regressions, the t-statistic does not have its usual distribution. We expect
that the same is true for more complicated scenarios, which are not tractable
analytically. In order to investigate the amount of bias in more complex
settings, we used the following 3 model combinations in our simulations.
5.1.1. Linear–linear. This is the most simple model and was also used in
the analytical analysis. Here, the internal and external models are standard
linear regressions. Let n be the number of subjects and p be the number of
predictors for the internal model. Let e be the number of external predictors.
Then the internal predictors are a matrix X which is generated as
Xij ∼N(0,1) i.i.d. i= 1, . . . , n, j = 1, . . . , p.
With β ∈Rp a user supplied vector, the response is generated as
y ∼N(Xβ, I · σ2I ).
From this true response, the external predictors are derived as
Zik ∼N(yi, σ2E) i.i.d. i= 1, . . . , n, k = 1, . . . , e.
The rationale for simulating the external predictors as a perturbation of
the truth rather than the underlying model is that the external predictors
would be derived using different models and may be targeting other aspects
of the phenomenon such that the underlying model here would not apply to
them. From this perspective, modeling them as a noisy version of the truth
seems more appropriate. For simplicity, we always choose σ2I = σ
2
E = 1 in the
simulations.
5.1.2. Lasso–linear. This model is an extension of the previous one. The
predictor matrix X is generated in exactly the same way as before. However,
only the first s components of β are being supplied by the user. The other
p− s components are set to 0 to ensure sparseness. The external predictors
are then generated from y as described above.
For analyzing this artificial data, an internal lasso regression model will
be used. The external model is linear regression as before. The internal
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model will be fit using the LARS algorithm [see Efron et al. (2004)], ensuring
that the fitted model contains exactly a prespecified number l of nonzero
coefficients. l is chosen by the user. More sophisticated methods are possible,
but outside the scope of this paper.
5.1.3. Linear Discriminant Analysis (LDA)–Logistic. This model is in-
tended to simulate something close to realistic applications on microarray
data. Again, there are n observations, which are divided into 2 groups with
n1 and n2 members (n1 + n2 = n). Also, p predictors (genes) will be gener-
ated for each observation independently. However, for the first s out of the
p genes, the means will be different. For the first group, µij = 0 ∀i, j, where
i refers to the observation and j to the genes. For the second group of n2
observations, the first s genes will have µij = µ > 0, a positive offset in the
mean from the same genes in the first group. All others genes will also have
mean 0 in the second group as well. Then we simulate the microarray data
as
Xij ∼N(µij, σ2).
The external predictors are then generated by switching the label of the yi
independently with probability pE .
In the internal model, first a number g of predictors is selected by choosing
the predictor with the largest correlation with the response. Then an LDA
model is fit to the chosen g predictors. The number g will be supplied by
the user. As above, automatic choices are possible, but as we just want to
demonstrate the performance of PV, we keep g fixed. In the external model,
standard logistic regression is used. For simplicity, we again choose σ = 1.
5.2. Simulation of the type I error under the null. In each of the scenarios
described above, we simulate artificial data and perform the PV algorithm
100,000 times (without the permutation test). The analytical p-value of the
pre-validated predictor is used to decide if the null hypothesis is rejected
(t-statistic in linear regression model, z-score in logistic regression). Based
on the simulations, the type I error of the analytical test is estimated (see
Table 6).
The analytical tests in the external models show substantial upward and
downward bias in the tested scenarios, depending on the choice of parame-
ters. For the type I error level 0.01, this upward bias can double the size of
the test and it is also substantial at level 0.05.
The remedy for this problem is a permutation test.
5.3. The permutation test. As we have just seen, the standard analytical
test in the external models used (here linear and logistic) do not achieve their
nominal level when they are being applied to pre-validated predictors. This
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Table 6
Type I error in various scenarios. Each estimate is based on 100,000 simulations, giving
an SD of ≤0.005. The most extreme values for each scenario are in bold
Type I error
Scenario Parameters CV-foldsα= 0.01α= 0.05α= 0.1
Linear–Linear n= 10, p= 5, k = 1, β = 0 5 0.022 0.079 0.137
10 0.024 0.080 0.139
n 0.023 0.083 0.140
n= 20, p= 5, k = 1, β = 0 5 0.018 0.069 0.123
10 0.017 0.066 0.120
n 0.018 0.067 0.119
n= 50, p= 5, k = 1, β = 0 5 0.016 0.064 0.115
10 0.016 0.062 0.111
n 0.015 0.060 0.109
Lasso–Linear n= 10, p= 100, k = 1, β = 0, s= 0, l = 5 5 0.008 0.033 0.062
10 0.011 0.040 0.072
n= 10, p= 100, k = 1, β = 0, s= 0, l= 10 5 0.010 0.040 0.074
10 0.016 0.053 0.091
n= 30, p= 100, k = 1, β = 0, s= 0, l = 5 5 0.012 0.040 0.071
10 0.014 0.046 0.076
n= 30, p= 100, k = 1, β = 0, s= 0, l= 10 5 0.016 0.054 0.092
10 0.021 0.065 0.105
n= 30, p= 100, k = 1, β = 0, s= 0, l= 20 5 0.020 0.065 0.112
10 0.030 0.081 0.128
LDA–Logisticn= 20, p= 1000, k = 1, β = 0, s= 0, g = 10 5 0.003 0.025 0.076
10 0.0096 0.047 0.100
n= 40, p= 1000, k = 1, β = 0, s= 0, g = 10 5 0.018 0.072 0.122
10 0.036 0.106 0.158
n= 80, p= 1000, k = 1, β = 0, s= 0, g = 10 5 0.019 0.071 0.122
10 0.053 0.126 0.179
can have serious consequences on the outcome of the test. A permutation
test is a procedure that is very robust with respect to this problem.
The external predictors have usually been used and validated in this con-
text before, so we were not concerned with evaluating their performance. In
any case, extending the permutation test to cover them as well is straight-
forward. The variables that we have as input is the response y, the internal
predictors X and the external predictors Z. As there is a relationship be-
tween y and Z, we do not permute y but instead the rows of X . Then, the
pre-validation procedure is used and a test statistic in the external model
collected (say β or t). This permutation is repeated often enough to get a
sufficiently large sample of the test statistic (here usually 500 or 1000 permu-
tations). The p-value is then estimated as the fraction of the permutation
test statistic larger or equal to the observed test statistic (no randomiza-
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tion on the boundary). As the pre-validated predictor is a prediction for
the response y, we expect its coefficient to be positive and therefore use a
one-sided p-value (as we already did for the analytical test).
The external predictors Z remain unchanged by the permutation, even if
they were derived with or are otherwise dependent on the internal data X .
Another possibility would be to model the dependency of Z on X and also
change Z when X is being permuted. We chose not to use this approach for
the following reasons:
• The model for deriving Z from X may be unknown. This would be the
case when the researcher was just provided with the clinically relevant
information.
• The exact underlying relationship between Z and X may be unknown.
If, say, X is microarray data and Z is derived from nonmicroarray data
(e.g., blood samples, tumor measurements, . . . ), it is still likely that there
is some relationship between these data types. This relationship may be
unknown so that it would be impossible to assess the effect of permuting
X on Z.
These problems make our method much easier to implement in practice.
Furthermore, the simulation results show that the method works well even
for dependent Z and X .
6. Simulation results. In this section we explore whether the permuta-
tion test achieves the intended level and what effect it has on the power
of the test compared to the analytical solution. For this, artificial datasets
according to the 3 scenarios described above are created and analyzed.
6.1. Level of the permutation test. For estimating the level of the test
under the null hypothesis, the internal predictors X will be independent of
the response and the external predictors Z. Several different parameter com-
binations will be used for this task. For each scenario and parameter choice,
1000 simulations were used where each test was based on 500 permutations.
All estimates are well within 2 standard deviations of their target value,
so we see that the permutation tests are unbiased. The simulated levels of
the permutation tests can be found in Tables 1, 2 and 3 of the Supporting
Online Material (SOM) [Ho¨fling and Tibshirani (2008)]. The standard error
for the α = 0.01 estimate is 0.003, for α = 0.05 it is 0.007 and for α = 0.1
the standard error is 0.009.
6.2. Power. The same scenarios that were used for estimating the level
of the permutation tests will also be used to estimate the power under the
alternative. As there is no distinct alternative hypothesis, several different
choices will be used, depending on the specific scenario.
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One of the most interesting aspects of this simulation is to compare the
power of the permutation test to the power of the standard analytical test.
However, as the analytical test is biased (usually upward), a straightforward
comparison using the nominal test levels is inappropriate. In order to adjust
for the bias, the simulations in the same scenario and parameters under the
null hypothesis will be used. For each nominal level, a new cutoff for the
p-values will be estimated such that the level of the analytical test is equal
to its nominal level. This cutoff will then also be used to estimate its power.
The power of the permutation test is in most cases very close to the
power of the analytical test and sometimes even higher (although this may
be a random occurrence). So, there does not seem to be a serious problem
with loss of power when comparing the permutation tests to the analytical
test. The simulated results can be seen in Tables 4, 5 and 6 of the SOM
[Ho¨fling and Tibshirani (2008)]. As before, the estimates are based on 1000
simulations, each of which used 500 permutations for the tests. Here, the
maximum standard deviation for the test is achieved for a power of 0.5, in
which case the SD is 0.016.
However, the picture as to which choice of test statistic and number of
folds to use for the permutation test is not very clear. For the Linear–Linear
model, we used 5-fold PV, 10-fold PV, leave-on-out PV and permutation
tests without PV (K = 1). For the other model, due to computation time
constraints, we only used 5- and 10-fold PV as well as no PV. In the Linear–
Linear scenario, leave-one-out PV performs slightly better than 5-fold and
10-fold PV. However, in all but the simplest models, performing leave-one-
out PV comes with a serious increase in computation time so that just using
5- or 10-fold PV may be considered appropriate.
In some instances, the permutation test using no PV showed a lot more
power than 5- or 10-fold PV permutation tests. However, especially in the
LDA–Logistic model, the test without PV had power even below the nominal
level of the test. This can be explained by overfitting the data, leading to
perfect separation of the classes even if there is no relationship between the
class labels y and the internal predictors X . In these cases, the permutation
test without PV does not give useable results.
Therefore, using the 5-fold (or 10-fold) PV permutation test is the most
reliable procedure, achieving the nominal level of the test without compro-
mising power with respect to the analytical test. The choice of test statistic
depends on the specific application, but all standard statistics we used had
acceptable performance.
6.3. Performance of the estimator for the pre-validated coefficient. When
the new prediction rule turns out to be a significant improvement over the
performance of the old prediction rules, the value of the coefficient of the
new predictor compared to the coefficients of the old predictors indicates
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how well the new predictor performs. Therefore, it is important to know
how well PV estimates the coefficient of the new prediction rule.
In order to have a comparison that is fair and relevant with respect to
the amount of data available, we estimate the coefficient using PV over 1000
simulation runs in the scenarios presented above. As a benchmark method,
we treat the dataset the PV was performed on as a training set to estimate
the new prediction rule and do the comparison to the other prediction rules
on an independently simulated test dataset of the same size as the train-
ing data. Our primary concern is that the coefficient estimated using PV is
roughly unbiased w.r.t. the benchmark. The most straightforward approach
would be to compare the mean over the simulations of the estimated coef-
ficient using PV and using the benchmark. However, in the LDA–Logistic
scenario, occasionally perfect separation occurs which makes the estimated
coefficients extremely large. Mean-unbiasedness is not applicable in this case
and we decided to use median-unbiasedness instead. As the difference be-
tween mean and median is quite small in all other scenarios and the median
is more robust, we used the median in the remaining scenarios as well [for
results see Table 10 of SOM; Ho¨fling and Tibshirani (2008)].
In general, PV tends to underestimate the coefficient compared to the
benchmark. The size of the underestimation depends on the scenario and
the number of folds used in PV. The performance in the Linear–Linear
model is very good with hardly any bias at all. For the Lasso–Linear and
the LDA–Logistic scenario, the bias is bigger. The difference of the estimates
for 5-fold and 10-fold PV show that at least part of the bias is due to the
smaller training set used for deriving the prediction rule in PV. The bias
also decreases with increasing number of observations, which can also be
explained this way, as removing a certain percentage of observations has a
smaller perturbing effect on the prediction rule when the total number of ob-
servations is large. Overall, PV does a good job of estimating the coefficient
of the new prediction rule.
7. Discussion. The problem often arises that, with a limited amount of
data, one wants to find a prediction rule and verify its usefulness on the same
dataset. Often, splitting the data into separate training and test sets [as in,
e.g., Chang et al. (2005)] is not feasible as there may not be enough samples
to achieve acceptable prediction performance and have enough observations
left to compare additional clinical predictors to the new prediction rule. Pre-
validation is a useful method to fill this gap and evaluate the significance and
prediction performance of the newly developed prediction rule. However, we
have found that using the standard analytical tests with the pre-validated
predictor can yield a test with level above the nominal level.
The permutation test approach to the pre-validated predictor addresses
the bias problem of the analytical test without compromising power and is
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therefore a more reliable way for assessing whether the new prediction rule
is an improvement over previously established predictors. Its main drawback
is that it is very computer-intensive, requiring us to refit the pre-validation
model for every permutation. This can be a problem for especially large
datasets. However, this will not often be a significant problem and the simple
structure of the algorithm makes it easily accessible to parallelization to
reduce computation time.
It might be possible to develop an analytical test that accounts for the
special structure of the pre-validated predictor. However, it is unclear if an
analytical solution exists that holds for a large number of models. Since the
internal models are usually tailored to the specific problem at hand, having
to derive analytical solutions on a case by case basis would be very difficult.
We believe that the permutation test is the best method currently available
for the problem.
APPENDIX: PROOFS
A.1. Case of no outside predictors. For the proof, we first need a lemma:
Lemma A1. Let Xij be i.i.d. N(0,1) for i = 1, . . . , n and j = 1, . . . , p.
Let H =Proj(X) =X(XTX)−1XT and D= diag(H). Then dii ∼OP (n−1).
Proof. By the strong law of large numbers, 1
n
XTX → Ip a.s. and as
taking the inverse of a matrix is a continuous operation,
n(XTX)−1→ Ip a.s.
Therefore,
ndii = nxi(X
TX)−1xTi
d→ χ2p
by continuous mapping, where xi is the ith row of X . 
Also note that as trace(H) =
∑
i dii = p, we have that Cov(dii, djj) <
0 ∀i 6= j.
Now let us move on to the proof of Theorem 1.
Proof of Theorem 1. Let the SVD of X be
X =UEV T ,
with U ∈ Rn×p orthogonal, E ∈ Rp×p diagonal and V ∈ Rp×p orthogonal.
Then we can write H = UUT , therefore, the leave-one-out pre-validated
predictor is
y˜ = (I −D)−1(UUT −D)y and βˆPV = y˜
Ty
y˜T y˜
.
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Evaluating the numerator, we get
y˜T y = yT (UUT −D)(I −D)−1y
= yTUUT y+ yTUUT ((I −D)−1 − I)y
− yTD((I −D)−1 − I)y − yTDy
d→NTN + 0− p as n→∞,
where N ∼ N(0, Ip). This holds as UT y ∼ N(0, Ip). The second term con-
verges to 0 as ((I −D)−1− I)∼OP (n−1) and UT y =N is bounded in prob-
ability. The third term converges to 0 in probability as D((I −D)−1− I)∼
OP (n
−2). For the fourth term observe that E(yTDy) = E(E(yTDy|X)) =
E(
∑
dii) = p. As Cov(dii, djj)< 0 for i 6= j, it is easy to show that yTDy P→ p.
For the denominator, we get
y˜T y˜ = yT (UUT −D)(I −D)−2(UUT −D)y
=NTN +NTUT ((I −D)−2 − I)UN
− 2yTD(I −D)−2UN + yTD2(I −D)−2y.
Here, the first term is NTN as above and the other terms converge to 0. The
second and third summand converge to 0 as (I − d)−2 − I ∼OP (n−1) and
D(I −D)−2 ∼OP (n−1) and for the fourth term we use that D2(I −D)−2 ∼
OP (n
−2).
Now that we have the distribution of the numerator and denominator of
βˆPV , consider sˆd(βˆPV ). This is estimated as
sˆd(βˆPV 0) = σˆ
√
y˜T y˜.
Only σˆ is left to treat, for which we can write
σˆ2 =
1
n− 1(y − βˆPV y˜)
T (y − βˆPV y˜)
=
1
n− 1(y
T y− 2βˆPV Y˜ ty+ βˆ2PV y˜T y˜).
We know that 1
n−1
yT y→ 1 a.s. The other terms go to 0, as it has been shown
above that the second and third summand inside the bracket is bounded in
probability.
So putting all this together yields the desired result. 
A.2. Case with outside predictors. The proof of Theorem 2 is along the
lines of the proof for Theorem 1, but with more complicated algebra.
First recall a well-known fact about the inverse of matrices. Assume we
have a matrix with blocks of the form
M =
(
A B
C D
)
,
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where A and D are nonsingular square-matrices. Then we can write the
inverse M−1 as
M−1 =
(
(A−BD−1C)−1 −(A−BD−1C)−1BD−1
−D−1C(A−BD−1C)−1 D−1 +D−1C(A−BD−1C)−1BD−1
)
.
The proof of Theorem 2 is then:
Proof of Theorem 2. Let β = (βPV , β
T
1 )
T and W = (y˜,Z). Then
βˆ = (W TW )−1W T y where W TW =
(
y˜T y˜ y˜TZ
ZT y˜ ZTZ
)
and as we are only interested in βˆPV , this can be written as
βˆPV = (y˜
T y˜ − y˜TZ(ZTZ)−1ZT y˜)−1(y˜T y − y˜TZ(ZTZ)−1ZTy),
using the formula for inverses of block matrices. Also define 1= (1, . . . ,1)T ∈
R
e. Then
1
n
ZTZ =
1
n
(y · 1T +Γ)T (y · 1T +Γ)
=
1
n
(yT y11T +2 · 1yTΓ+ ΓTΓ)
P→ 11T +0+Cov(γ),
where Γik = γik is the matrix of random errors of the external predictors
and the convergence follows by the weak law of large numbers.
Also,
1
n
ZT y =
1
n
(1yT y +ΓT y)
P→ 1+0,
again using the weak law of large numbers and the independence of Γ and y.
Furthermore ZT y˜ = 1yT y˜+ΓT y˜. As we already know that yT y˜
d→NTN − p
where N ∼N(0, Ip), we only have to determine the distribution of
ΓT y˜ = ΓT (I −D)−1(H −D)y
= ΓT (I −D)−1UUT y− ΓT (I −D)−1Dy
d→ATN − 0,
where N = UT y ∼ N(0, Ip) and UT (I − D)−1Γ d→ A = (A1, . . . ,Ae) with
Ak ∼N(0, σ2k · Ip)) i.i.d. So ZT y˜ converges in distribution to
ZT y˜
d→NTN − p+ATN.
So combining the previous results, we have
y˜TZ(ZTZ)−1ZT y˜ =
1
n
(
y˜TZ
(
1
n
ZTZ
)
−1
ZT y˜
)
P→ 0,
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as the term inside the brackets is bounded in probability. Also,
y˜TZ(ZTZ)−1ZT y
= y˜TZ
(
1
n
ZTZ
)
−1 1
n
ZT y
d→ (1T (NTN − p) +NTA)(11T +Cov(γ))−11.
Combining all this, we have that
βˆPV
d→ N
TN − p− (1T (NTN − p) +NTA)(11T +Cov(γ))−11
NTN
=
(NTN − p)(1− 1T (11T +Cov(γ))−11)−NTA(11T +Cov(γ))−11
NTN
.
In order to get the distribution of the t-statistic, the distribution of
sˆd(βˆPV ) =
√
(W TW )−1
11
σˆ
is needed. First, consider (W TW )−1
11
:
(W TW )−1
11
= (y˜T y˜ − y˜TZ(ZTZ)−1ZT y˜)−1 d→ (NTN)−1
as y˜TZ(ZTZ)−1ZT y˜ = 1
n
y˜TZ( 1
n
ZTZ)−1ZT y˜
P→ 0. Next determine the asymp-
totic distribution of σˆ:
σˆ =
1
n− e− 1(y− yˆ)
T (y − yˆ)
=
1
n− e− 1(y
T y− yTW (W TW )−1W T y).
As before, 1
n−e−1
yT y
P→ 1. For the second term, first observe that
1
n
W T y
P→
(
0
1
)
.
For 1
n
(W TW )−1, it is simple to show that all elements are asymptotically
bounded in probability. For σˆ, only the bottom right block is needed, where
1
n
(W TW )−1
22
P→ (11T +Cov(γ))−1 as n→∞.
Therefore,
σˆ
d→ 1− 1T (11T +Cov(γ))−11.
Combining these results yields the claim. 
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